EMCDDA and ECDC join forces to address the challenge of hepatitis

News-13 Jun 2017

Hepatitis and other drug-related infectious diseases will be the focus of ‘Hepatitis week’, taking place at the EU drugs agency (EMCDDA) in Lisbon from 12–16 June 2017. The initiative will bring together some 100 specialists from: EU Member States, candidate and potential candidate countries to the EU, as well as partner agencies, civil society and professional organisations.

ECDC Director Marc Sprenger: “Hepatitis B and C are a serious health problem in the EU, tailor-made screening is important”Archived

News-23 May 2011

ECDC Director Marc Sprenger at the European Parliament Committee on the Environment, Public Health and Food Safety (ENVI) stressed the importance of the EU’s continuous commitment in the fight against hepatitis B and hepatitis C.